Pelvic floor muscle training associated with the photobiomodulation therapy for women affected by the genitourinary syndrome of menopause: a study protocol [PDF]
PeerJBackground Frequently, the women affected by the genitourinary syndrome of menopause experience genitourinary dysfunctions that profoundly influence their overall health.
Lívia Oliveira Bezerra +5 more
doaj +4 more sources
Genitourinary Syndrome of Menopause: A Systematic Review [PDF]
Genitourinary syndrome is the most common health problem experienced by postmenopausal women. Its pathogenesis is correlated with decreased estrogen levels, which results in thinner vaginal epithelium with a reduced proportion of superficial cells.
Sri Hayati, Tukimin Bin Sansuwito
core +4 more sources
Hormone therapy for genitourinary syndrome of menopause: reality and prospects
Клинический разбор в общей медицинеGenitourinary syndrome of menopause still represents one of the most pressing unresolved issues of modern gynecology. High prevalence and the data suggesting a marked decline in the quality of life in general and sexual life in particular in patients of ...
Mekan R. Orazov +2 more
doaj +3 more sources
Relationships between the vaginal microbiota and genitourinary syndrome of menopause symptoms in postmenopausal women: the Study of Women's Health Across the Nation [PDF]
Menopause, 2023 ObjectiveTo describe vaginal microbiota classified by community state types (CST) in a diverse cohort of postmenopausal women and evaluate relationships among genitourinary syndrome of menopause (GSM) symptoms (vaginal dryness, vulvovaginal irritation ...
Brooks, Maria M +7 more
core +3 more sources
A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause [PDF]
MenopauseWomen who suffer from genitourinary syndrome of menopause were treated with either vaginal estrogen or vaginal hyaluronic acid, and both groups noted improvement in symptoms after 12 wk of treatment.
Surbhi Agrawal +8 more
europepmc +4 more sources
A Novel Intrauterine Device for the Spatio-Temporal Release of Norethindrone Acetate as a Counter-Estrogenic Intervention in the Genitourinary Syndrome of Menopause [PDF]
PharmaceuticsThe genitourinary syndrome of menopause (GSM) is a widely occurring condition affecting millions of women worldwide. The current treatment of GSM involves the use of orally or vaginally administered estrogens, often with the risk of endometrial ...
Ahmed Abdelgader +3 more
europepmc +3 more sources
Role of Platelet-Rich Plasma in Genitourinary Syndrome of Menopause [PDF]
CureusThe genitourinary syndrome of menopause (GSM) encompasses a range of symptoms linked to the genitourinary tract stemming from the reduction in estrogen levels following menopause. These symptoms may endure throughout a woman's lifetime.
Tejal Waghe +5 more
europepmc +3 more sources
Vaginal Estrogen for Genitourinary Syndrome of Menopause [PDF]
Obstetrical & Gynecological Survey, 2014 To comprehensively review and critically assess the literature on vaginal estrogen and its alternatives for women with genitourinary syndrome of menopause and to provide clinical practice guidelines.MEDLINE and Cochrane databases were searched from inception to April 2013.
Cassandra Carberry +9 more
openaire +4 more sources
The Genitourinary Syndrome of Menopause: An Overview of the Recent Data [PDF]
Cureus, 2020 The genitourinary syndrome of menopause (GSM) is a relatively new term for the condition previously known as vulvovaginal atrophy, atrophic vaginitis, or urogenital atrophy. The term was first introduced in 2014. GSM is a chronic, progressive, vulvovaginal, sexual, and lower urinary tract condition characterized by a broad spectrum of signs and ...
Themos Grigoriadis +4 more
openaire +4 more sources
BMC Women's Health, 2021 Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement.
Laura Baquedano Mainar +5 more
doaj +2 more sources